bibliographic resource 4281923 [br/4281923]
https://w3id.org/oc/corpus/br/4281923

is a
title
  • CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).
publication date
  • 2014-01-01
contributor
format
identifier
part of